Katznelson L, Alexander J M, Bikkal H A, Jameson J L, Hsu D W, Klibanski A
Neuroendocrine Unit, Massachusetts General Hospital, Boston 02114.
J Clin Endocrinol Metab. 1992 Jun;74(6):1343-51. doi: 10.1210/jcem.74.6.1375599.
Clinically nonfunctioning pituitary adenomas represent approximately 25% of all pituitary tumors. Recent studies using a number of in vitro techniques show that the majority of such tumors produce gonadotropins. Hypersecretion of uncombined gonadotropin subunits by these tumors has also been identified raising the possibility that gonadotropin biosynthetic alterations may occur in neoplastic pituitary tissue. To determine whether underlying intracellular biosynthetic alterations lead to imbalanced secretion of the gonadotropin subunits by such tumors, we investigated 1) steady state gonadotropin-subunit messenger ribonucleic acid (mRNA) levels in tumor tissue from 49 patients with clinically nonfunctioning adenomas, 2) secretion of gonadotropins in dispersed pituitary tumor cultures, and 3) serum concentrations of gonadotropins and free subunits. Northern blots of RNA extracted from surgically obtained pituitary tumor tissue were hybridized with complementary DNA probes for FSH beta, LH beta, and alpha-subunit, and quantitative analysis was done to compare alpha- and beta-subunit biosynthesis in individual tumors. Of these tumors, 47 contained sufficient RNA for Northern analysis and 77% of these tumors contained one or more of the gonadotropin-subunit mRNAs. Steady state alpha-subunit mRNA was detected in 57% of tumors, FSH beta mRNA in 49%, and LH beta in 1 (2%). We found FSH beta mRNA in excess of alpha-subunit mRNA in one-third of tumors, including 9 tumors where alpha-subunit mRNA was undetectable. In cultured cells, FSH beta was secreted in excess of alpha-subunit in 41% of tumors. For those tumors in which both mRNA and culture data were available, FSH beta mRNA and secreted subunit levels were in excess of alpha-subunit in 64% of tumors. We conclude that clinically nonfunctioning pituitary adenomas frequently synthesize excess FSH beta subunit relative to alpha-subunit. This finding is in contrast to previous data in normal pituitary or placental tissue where alpha-subunit is present in excess of beta-subunits at both the mRNA and protein levels. The free-beta-subunit hypersecretion identified in pituitary adenomas may be due to biosynthetic abnormalities intrinsic to neoplastic gonadotrophs.
临床上无功能垂体腺瘤约占所有垂体肿瘤的25%。最近使用多种体外技术的研究表明,这类肿瘤中的大多数会产生促性腺激素。这些肿瘤未结合的促性腺激素亚基分泌过多,这也增加了垂体肿瘤组织中可能发生促性腺激素生物合成改变的可能性。为了确定潜在的细胞内生物合成改变是否导致这类肿瘤促性腺激素亚基分泌失衡,我们进行了以下研究:1)检测49例临床无功能腺瘤患者肿瘤组织中促性腺激素亚基信使核糖核酸(mRNA)的稳态水平;2)检测分散的垂体肿瘤培养物中促性腺激素的分泌情况;3)检测血清中促性腺激素和游离亚基的浓度。用手术获取的垂体肿瘤组织提取的RNA进行Northern印迹分析,与促卵泡激素β(FSHβ)、促黄体生成素β(LHβ)和α亚基的互补DNA探针杂交,并进行定量分析以比较单个肿瘤中α亚基和β亚基的生物合成情况。在这些肿瘤中,47个含有足够的RNA用于Northern分析,其中77%的肿瘤含有一种或多种促性腺激素亚基mRNA。57%的肿瘤检测到α亚基mRNA稳态水平,49%检测到FSHβ mRNA,1个(2%)检测到LHβ mRNA。我们发现三分之一的肿瘤中FSHβ mRNA水平超过α亚基mRNA,其中9个肿瘤未检测到α亚基mRNA。在培养细胞中,41%的肿瘤分泌的FSHβ超过α亚基。对于那些同时有mRNA和培养数据的肿瘤,64%的肿瘤FSHβ mRNA和分泌的亚基水平超过α亚基。我们得出结论,临床无功能垂体腺瘤相对于α亚基经常合成过量的FSHβ亚基。这一发现与正常垂体或胎盘组织中先前的数据相反,在正常组织中,无论是mRNA水平还是蛋白质水平,α亚基都过量于β亚基。垂体腺瘤中游离β亚基分泌过多可能是由于肿瘤性促性腺细胞固有的生物合成异常。